Protective Effect of Paraoxonase 1 Gene Variant Gln192Arg in Age-Related Macular Degeneration
- 1 March 2010
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 149 (3) , 513-522
Abstract
No abstract availableKeywords
Funding Information
- US National Institute of Health, Bethesda, Maryland (EY015638, EY016072)
- State of Ohio (BRTT 05-29)
- Foundation Fighting Blindness Center, Owings Mills, Maryland
- Research to Prevent Blindness (RPB) Center, New York, New York
This publication has 40 references indexed in Scilit:
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJAMA, 2008
- Paraoxonase 1: Genetics and Activities During AgingRejuvenation Research, 2008
- Macular DegenerationAnnual Review of Medicine, 2007
- Mutation screen of the TUB gene in patients with retinitis pigmentosa and Leber congenital amaurosisExperimental Eye Research, 2006
- Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degenerationNature Genetics, 2006
- Serum Paraoxonase 1 Activity and Lipid Peroxidation Levels in Patients with Age-Related Macular DegenerationOphthalmologica, 2005
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- Association study of detoxification genes in age related macular degenerationBritish Journal of Ophthalmology, 2005
- Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degenerationAmerican Journal of Ophthalmology, 2004
- Genetics of plasma paroxonase activityJournal of Medical Genetics, 1982